Novavax
NVAX
#5532
Rank
โ‚น123.10 B
Marketcap
โ‚น755.55
Share price
-4.81%
Change (1 day)
61.43%
Change (1 year)

Novavax (NVAX) - Total debt

Total debt on the balance sheet as of December 2025 : โ‚น23.15 Billion

According to Novavax's latest financial reports the company's total debt is โ‚น23.15 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novavax - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2025-12-31โ‚น22.33 B13%
2024-12-31โ‚น19.76 B3.65%
2023-12-31โ‚น19.07 B-58.08%
2022-12-31โ‚น45.49 B34.63%
2021-12-31โ‚น33.79 B-1.27%
2020-12-31โ‚น34.22 B49.11%
2019-12-31โ‚น22.95 B2.84%
2018-12-31โ‚น22.31 B10%
2017-12-31โ‚น20.28 B-5.62%
2016-12-31โ‚น21.49 B81793.25%
2015-12-31โ‚น26.24 M-58.5%
2014-12-31โ‚น63.25 M-45.57%
2013-12-31โ‚น0.11 B76.13%
2012-12-31โ‚น65.97 M289.75%
2011-12-31โ‚น16.92 M-5.56%
2010-12-31โ‚น17.92 M-20.52%
2009-12-31โ‚น22.55 M-97.95%
2008-12-31โ‚น1.10 B23.33%
2007-12-31โ‚น0.89 B-13.07%
2006-12-31โ‚น1.02 B-25.25%
2005-12-31โ‚น1.37 B-14.64%
2004-12-31โ‚น1.60 B-16.16%
2003-12-31โ‚น1.91 B-3.31%
2002-12-31โ‚น1.98 B19.84%
2001-12-31โ‚น1.65 B77.5%
2000-12-31โ‚น0.93 B21371.69%
1999-12-31โ‚น4.34 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
โ‚น3.291 T 14,118.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น5.951 T 25,606.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น2.712 T 11,615.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น2.220 T 9,491.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚น96.74 B 317.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น0.21 B-99.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น4.25 B-81.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น0.13 B-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น40.83 B 76.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น61.70 B 166.51%๐Ÿ‡บ๐Ÿ‡ธ USA